Adverum Biotechnologies, Inc. - COM (ADVM)

Historical Portfolio Holders from Q1 2016 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
3.58 M
Holdings value Q1 2024
$50.7 M
Value change Q1 2024
-$61.4 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
3
Number of buys Q1 2024
2
Number of sells Q1 2024
-56
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.003%
CUSIP
00773U108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 3.58 M $50.7 M -$61.4 M $14.14 3
2023 Q4 58.8 M $44.3 M +$29.2 M $0.75 56
2023 Q3 9.26 M $13.9 M -$57.2 K $1.50 8
2023 Q2 65.5 M $104 M +$5.75 M $1.59 55
2023 Q1 61.3 M $44 M +$4.08 M $0.72 51
2022 Q4 57.1 M $33.1 M -$6.72 M $0.58 56
2022 Q3 58.5 M $55.6 M -$1.21 M $0.95 71
2022 Q2 57.9 M $69.5 M -$6.74 M $1.20 66
2022 Q1 62.1 M $81.4 M -$1.33 M $1.31 80
2021 Q4 65.4 M $115 M -$8.01 M $1.76 93
2021 Q3 60.7 M $132 M -$22.9 M $2.17 105
2021 Q2 76.4 M $267 M -$216 M $3.50 114
2021 Q1 95.1 M $938 M +$10.3 M $9.86 130
2020 Q4 91.7 M $994 M -$15.9 M $10.84 148
2020 Q3 94.7 M $975 M +$112 M $10.30 152
2020 Q2 80.6 M $1.68 B +$34.6 M $20.88 137
2020 Q1 79.1 M $773 M +$235 M $9.77 117
2019 Q4 55.6 M $641 M +$34.2 M $11.52 110
2019 Q3 48.5 M $265 M -$13.1 M $5.45 95
2019 Q2 46.3 M $548 M +$95.4 M $11.89 91
2019 Q1 39.6 M $208 M +$8.79 M $5.24 81
2018 Q4 38.2 M $120 M -$9.94 M $3.15 80
2018 Q3 34.4 M $208 M -$12.8 M $6.05 101
2018 Q2 36.6 M $194 M +$9.8 M $5.30 99
2018 Q1 34.6 M $201 M +$91.8 M $5.80 95
2017 Q4 19.2 M $67.3 M +$19.6 M $3.50 63
2017 Q3 13.6 M $49.5 M +$3.29 M $3.65 55
2017 Q2 13 M $32.5 M -$1.44 M $2.50 59
2017 Q1 13.5 M $36.5 M +$2.26 M $2.70 70
2016 Q4 15.1 M $43.8 M -$555 K $2.90 77
2016 Q3 15.3 M $62.7 M -$937 K $4.11 73
2016 Q2 15.8 M $49.8 M +$49.1 M $3.16 74
2016 Q1 220 K $1.14 M +$1.14 M $5.16 2